EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice

Nidha Shapoo iD, Noella Boma, Vladimir Gotlieb, Joseph Mattana, Regina Belokovskaya, Alberto Franco

Medical Sciences · 26.06.2026 · 14 (3) · 347

DOI: 10.3390/medsci14030347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 26.06.2026. Verfasst von Nidha Shapoo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYC Health & Hospitals/Metropolitan Hospital, New York Medical College, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Neoplasms, Endocrine System Diseases, Endocrinology, Medical Oncology. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of immune checkpoint inhibitors, targeted therapies, CAR T-cell therapy, and antibody–drug conjugates has transformed modern oncology, significantly improving survival across a wide range of malignancies. However, these advances have also introduced a growing spectrum of endocrine and metabolic complications, redefining the scope of endocrine practice. Therapy-induced endocrinopathies, including thyroid dysfunction, hypophysitis, adrenal insufficiency, diabetes, pancreatitis, dyslipidemia, gonadal dysfunction, and metabolic syndrome, are recognized as clinically significant and often long-lasting consequences of cancer treatment. Unlike classical endocrine disorders, these conditions frequently present abruptly, display atypical clinical patterns, and require complex multidisciplinary management. This review explores the evolving field of oncoendocrinology, focusing on the mechanisms, clinical manifestations, and management of endocrine toxicities associated with novel cancer therapies. We also discuss the long-term endocrine sequelae of cancer treatment and the growing need for structured survivorship care and endocrine surveillance. In addition, we discuss future directions in oncoendocrinology, including predictive biomarkers, the need for treatment standardization, integrated care models, survivorship surveillance, and precision-based approaches to endocrine care. As cancer survival continues to improve, early recognition and long-term management of endocrine complications are becoming essential to optimizing both quality of life and overall outcomes in cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsEndocrine System DiseasesEndocrinologyMedical OncologyHumans

Stichwörter der Autor:innen

endocrine toxicitiesfuture directionhyperglycemiaimmunotherapyoncoendocrinologypersonalized caresurvivorshiptargeted therapiesthyroid dysfunction

Autor:innen und Institutionen

  • Department of Medicine, NYC Health & Hospitals/Metropolitan Hospital, New York Medical College, New York, NY 10029, USA.

ORCID-Profile: Nidha Shapoo

Zitieren

APA

Shapoo, N., Boma, N., Gotlieb, V., Mattana, J., Belokovskaya, R., & Franco, A. (2026). The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice. Medical Sciences, 14(3), 347. https://doi.org/10.3390/medsci14030347

Vancouver

Shapoo N, Boma N, Gotlieb V, Mattana J, Belokovskaya R, Franco A. The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice. Medical Sciences. 2026;14(3):347. doi:10.3390/medsci14030347

BibTeX
@article{Shapoo2026,
  author = {Shapoo, Nidha and Boma, Noella and Gotlieb, Vladimir and Mattana, Joseph and Belokovskaya, Regina and Franco, Alberto},
  title = {The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {347},
  doi = {10.3390/medsci14030347}
}
Kostenlos starten →